Cyclezyme AbNGM: CYCLE

CYCLE: Losses increased as sales fell to zero, but a key patent and scaling projects mark strategic progress

· Issued by Cyclezyme AB

Net sales dropped to zero and losses widened in Q1 2026 as investments in technology and patents continued. A key European patent was granted, and major development projects with partners are advancing, positioning the company for future commercialization.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Cyclezyme Ab

All Cyclezyme Ab news releases